Clorox (NYSE:CLX) Shares Unloaded Rep. Lisa C. McClain

Representative Lisa C. McClain (R-Michigan) recently sold shares of The Clorox Company (NYSE:CLX). In a filing disclosed on November 21st, the Representative disclosed that they had sold between $1,001 and $15,000 in Clorox stock on October 30th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Coherent (NYSE:COHR) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Clorox (NYSE:CLX) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Northern Trust (NASDAQ:NTRS) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Honda Motor (NYSE:HMC) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Home BancShares (NYSE:HOMB) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Five Below (NASDAQ:FIVE) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Pure Storage (NYSE:PSTG) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of BHP Group (NYSE:BHP) on 10/31/2025.

Clorox Price Performance

CLX traded up $0.88 during midday trading on Thursday, reaching $107.75. 1,632,970 shares of the company’s stock were exchanged, compared to its average volume of 1,753,730. The business’s 50-day moving average price is $114.23 and its 200 day moving average price is $121.67. The stock has a market capitalization of $13.14 billion, a PE ratio of 16.53, a P/E/G ratio of 0.92 and a beta of 0.52. The Clorox Company has a 1-year low of $98.20 and a 1-year high of $171.37. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. The company had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. Clorox’s revenue for the quarter was down 18.9% on a year-over-year basis. During the same quarter last year, the business earned $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, equities analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 28th will be issued a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a yield of 4.6%. The ex-dividend date is Wednesday, January 28th. Clorox’s dividend payout ratio (DPR) is 77.86%.

Analyst Upgrades and Downgrades

Several research firms have issued reports on CLX. Jefferies Financial Group restated a “buy” rating and set a $152.00 price objective on shares of Clorox in a report on Tuesday, November 4th. BNP Paribas Exane decreased their price target on shares of Clorox from $110.00 to $103.00 and set an “underperform” rating for the company in a research report on Tuesday, November 4th. Wells Fargo & Company dropped their price target on shares of Clorox from $125.00 to $117.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 4th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Clorox from $128.00 to $121.00 and set a “hold” rating on the stock in a research note on Tuesday, November 4th. Finally, UBS Group set a $119.00 target price on shares of Clorox and gave the stock a “neutral” rating in a research report on Tuesday, November 4th. One equities research analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and five have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Clorox currently has an average rating of “Reduce” and an average price target of $125.69.

Institutional Trading of Clorox

Institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. increased its position in Clorox by 1.7% in the second quarter. Vanguard Group Inc. now owns 15,845,496 shares of the company’s stock worth $1,902,569,000 after buying an additional 272,420 shares during the period. State Street Corp grew its position in shares of Clorox by 3.5% during the third quarter. State Street Corp now owns 8,434,277 shares of the company’s stock worth $1,039,946,000 after acquiring an additional 282,794 shares during the last quarter. Invesco Ltd. grew its position in shares of Clorox by 23.1% during the third quarter. Invesco Ltd. now owns 3,995,590 shares of the company’s stock worth $492,656,000 after acquiring an additional 750,415 shares during the last quarter. Van ECK Associates Corp lifted its position in Clorox by 93.9% in the 3rd quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock valued at $334,139,000 after purchasing an additional 1,312,471 shares during the last quarter. Finally, Two Sigma Investments LP boosted its stake in Clorox by 33.8% during the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock valued at $214,564,000 after purchasing an additional 439,797 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the sale, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Pierre R. Breber acquired 4,000 shares of Clorox stock in a transaction dated Friday, November 21st. The shares were acquired at an average price of $104.13 per share, with a total value of $416,520.00. Following the completion of the transaction, the director owned 13,000 shares of the company’s stock, valued at approximately $1,353,690. This trade represents a 44.44% increase in their position. The SEC filing for this purchase provides additional information. 0.63% of the stock is currently owned by corporate insiders.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.